MAS
CRL icon

Meeder Advisory Services’s Charles River Laboratories CRL Stock Holding History

Meeder Advisory Services’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$251K Sell
1,457
-35
-2% -$6.49K 0.01% 579
2025
Q4 		$298K Buy
1,492
+181
+14% +$32.8K 0.01% 528
2025
Q3 		$205K Buy
+1,311
New +$208K 0.01% 596

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Meeder Advisory Services's CRL Position: Q1 2026 in Review

Meeder Advisory Services reduced its Charles River Laboratories (CRL) stake by 2.3% in Q1 2026, selling an estimated $6.49K and leaving 1,457 shares worth $251K. The position accounts for 0.01% of the portfolio, ranked #579.

Meeder Advisory Services first reported a position in CRL in Q3 2025 and has held it in 3 quarters since. The position peaked at $298K in Q4 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Meeder Advisory Services held 1,457 shares of Charles River Laboratories worth $251K as of Q1 2026.
  • Meeder Advisory Services sold 35 Charles River Laboratories shares in Q1 2026, an estimated $6.49K.
  • Charles River Laboratories made up 0.01% of Meeder Advisory Services's portfolio in Q1 2026, its #579 holding.
  • Meeder Advisory Services first reported a position in Charles River Laboratories in Q3 2025 and has held it in 3 quarters since.
  • Meeder Advisory Services's Charles River Laboratories position peaked at $298K in Q4 2025.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.